LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches
LTS has received a grant from the Bill & Melinda Gates Foundation for support new formulation methods for mRNA.
LTS hands over donations of € 60,000 to the Hoffnungswerk and the Koblenz Hospice Association
LTS hands over donations of € 60,000 to the Hoffnungswerk and the Koblenz Hospice Association
The LTS SorrelTM Platform – Solving Dilemmas in the fill/finish process
Watch our webcast with Greg Moakes talking about “The LTS SorrelTM Platform – Solving Dilemmas in the fill/finish process”.
LTS Advances Quality Oversight with Veeva Vault QMS
Leading pharmatech unifies quality processes for greater efficiency, collaboration, and compliance
Micro array patch technology: Turning early-adopter status into first mover advantage
When it comes to the take up of innovative technologies, early adoption is always a double-edged sword. Conceivably, there are greater risks involved, but there are also undoubtedly greater rewards on offer.
LTS completes its entry into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business.
LTS has completed its acquisition of the Sorrel wearable injection device business with headquarters in Netanya, Israel, from Eitan Medical Ltd.
LTS donates bed bike to St. Nikolaus-Stiftshospital in Andernach
The hospital had invited LTS to demonstrate the MOTOmed bed bike that we had donated to the hospital.
Interview with Claudia Schaefer: Our drive towards continuous improvement in efficacy, quality, and people utilization
Here, Dr. Claudia Schaefer explains the factors that are driving continuous improvement in both areas to the benefit of pharmaceutical customers.
LTS donates 40 trees for the project “Roots for All”
LTS ist participating in the "Roots for All" project in the Neuwied municipal forest with a sustainable donation of 40 trees.
LTS expands into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business
LTS, a leading pharmaceutical technology company announces the signing of the acquisition of the Sorrel wearable injection device business a part of the Eitan Medical Ltd.